Phase II study of neoadjuvant checkpoint blockade in patients with surgically resectable undifferentiated pleomorphic sarcoma and dedifferentiated liposarcoma
BACKGROUND: Soft tissue sarcomas (STSs) are a diverse group of cancers that originate from mesenchymal tissue and are estimated to result in 13,130 new cases and 5,350 deaths this year. These neoplasms are hard to detect, which results in physicians struggling to treat late-stage STSs with a limited...
Main Author: | |
---|---|
Other Authors: | |
Language: | en_US |
Published: |
2020
|
Subjects: | |
Online Access: | https://hdl.handle.net/2144/41151 |